Genmab A/S Financial Overview
Genmab A/S's market cap is currently kr126.75B. The company's EPS TTM is kr40.9807466418; its P/E ratio is 12.88; Genmab A/S is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is kr27.06. See an overview of income statement, balance sheet, and cash flow financials.
